Oncology

The CGTLive™ Oncology specialty topic page highlights the latest clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various cancers. It also houses video interviews with key opinion leaders in the field of oncology speaking to the related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for oncologic diseases.

Latest News

China's NMPA Accepts Satri-Cel NDA for Filing

By Noah Stansfield

July 7th 2025

The NDA is supported primarily by data from the phase 2 CT041-ST-01 randomized controlled clinical trial.

Alexey Danilov, MD, PhD, the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, co-director of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California

Optimal Use of CAR T-Cell Therapy, Bispecifics, and Other Novel Strategies Will Determine the Future of DLBCL Therapy

By Alexey Danilov, MD, PhD
Courtney Flaherty

July 6th 2025

Cell Therapy’s Lot in Solid Tumors: Challenges and Opportunities

By Noah Stansfield

July 5th 2025

CGTLive®’s Weekly Rewind – July 4, 2025

By Noah Stansfield

July 4th 2025

FDA Drops REMS Requirement for 6 Approved CAR T-Cell Therapies

By Noah Stansfield

July 3rd 2025

Latest CME Events & Activities

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

Community Practice Connections™: 6th Annual Precision Medicine Symposium – An Illustrated Tumor Board

Medical Crossfire®: Expert Interpretations of the Latest Data in CLL Management – Understanding the Impact of Optimal Treatment Selection on Patient Outcomes

Community Practice Connections™: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer

More News

Saurabh Dahiya, MD, from Stanford University School of Medicine

CD19/20-Targeted KITE-363 Elicits Strong Response in LBCL

Silas Inman

May 31st 2025

KITE-363 shows promising results in treating relapsed/refractory large B-cell lymphoma, with high response rates and manageable adverse events.

Changsong Qi, MD, PharmD, of the Peking University Cancer Hospital, in Beijing, China

Satri-cel Makes Strides in Gastric and Gastroesophageal Junction Cancer

Matt Hoffman

May 31st 2025

The CAR T-cell therapy showed promise in treating advanced gastric cancer by demonstrating improved survival rates and safety in pivotal trial results.